Dyno Nobel Limited (ASX:DNL): What Do FY26 Earnings and FY27 Guidance Reveal?

Aditi Sarkar

10 November 2026 04:17 PM AEDT

Dyno Nobel Limited (ASX:DNL): What Do FY26 Earnings and FY27 Guidance Reveal?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Dyno Nobel (ASX:DNL) traded at AUD 3.42 on 10 November 2026, up 0.59% during the session.
FY26 explosives underlying EBIT reached AUD 485 million, up 12% on the comparable basis.
Group statutory net profit after tax was AUD 66 million for the year ended 30 September 2026.
FY27 underlying EBIT guidance stands at approximately AUD 515 million to AUD 555 million.

Dyno Nobel Limited (ASX:DNL) manufactures commercial explosives and initiating systems and provides blasting services to mining, quarrying and construction customers across international markets. On 10 November 2026, the company's shares were trading at AUD 3.42, a rise of 0.59% for the session. The market update followed its release of FY26 results on 9 November, which detailed Earnings from its continuing explosives business, the completed separation of fertiliser operations and financial guidance for FY27. These developments place operating performance, project execution and the cost of growth at the centre of the company's current reporting cycle.

Explosives Operations and Geographic Reach

Dyno Nobel Limited (ASX:DNL) supplies bulk explosives, initiating systems and technical services used in surface and underground blasting. Its activities span Australia, North America and other international markets. The Business supports customers through Manufacturing facilities, delivery systems, engineering expertise and mine-site services, with Demand linked to Mining volumes, quarry activity and customer contracts.

The company's continuing explosives operations are reported across Asia Pacific, the Americas, and Europe and Latin America. Their earnings can differ because of customer mix, manufacturing utilisation, contract pricing, input costs and local operating conditions. Its technical offering also includes electronic initiation and systems designed to improve the consistency and monitoring of blast operations.

FY26 Results and Portfolio Changes

For the financial year ended 30 September 2026, Dyno Nobel Limited (ASX:DNL) reported group Revenue of approximately AUD 3.941 billion, down 26% as its portfolio changed following the exit from fertilisers. Revenue from the continuing explosives business was approximately AUD 3.406 billion. The company reported underlying explosives earnings before interest and tax (EBIT) of AUD 485 million, a 12% increase on its comparable basis, and underlying explosives EBITDA of about AUD 759 million.

Group statutory net profit after tax was AUD 66 million, compared with a statutory loss in FY25. Profit excluding individually material items was approximately AUD 331 million. These measures describe different scopes: statutory results include the effects of discontinued activities and material items, while underlying explosives earnings focus on continuing operations. They should not be treated as interchangeable indicators of profitability.

The sale of Phosphate Hill, completed in June 2026, concluded the separation of the fertilisers manufacturing business. Dyno Nobel also declared a final Dividend of 5.0 Australian cents per share, 50% franked, with payment scheduled for 18 December 2026. The dividend Record Date is 4 December 2026. Capital allocation remains relevant as the company balances distributions, operational Investment and its balance sheet.

Technology, Contracts and FY27 Outlook

During September 2026, Dyno Nobel Limited (ASX:DNL) presented an Autonomous Bench prototype designed to coordinate blast-hole measurement, priming, loading, stemming and recording from a remote control centre. The company outlined a staged rollout pathway towards mid-2027, beginning with trials in the United States. A prototype and planned trials do not establish commercial deployment or future revenue, and further testing and customer adoption remain important milestones.

Dyno Nobel also reported the award of a USD 581 million IMX project to the Nitradyn joint venture. The project adds to its activity in defence-related energetics, although the timing of construction, investment and earnings recognition will determine its eventual financial contribution. The company moved its global headquarters to Brisbane during 2026, aligning corporate functions more closely with its Australian operations.

For FY27, Dyno Nobel Limited (ASX:DNL) guided to underlying EBIT of approximately AUD 515 million to AUD 555 million. Management indicated that earnings would be weighted towards the second half, with planned manufacturing maintenance among the relevant operational considerations. Guidance represents management's current expectations, not an assured result, and remains sensitive to customer activity, production reliability, costs and foreign-exchange movements.

Risks and What to Monitor Next

The explosives business faces manufacturing downtime, supply-chain interruptions, energy and raw-material price changes, workplace safety risks and variations in mining customer demand. Its international operations also expose earnings to currency movements and differing regulatory requirements. Development of autonomous blasting technology and energetics projects involves testing, commissioning and execution risks. Investors can monitor FY27 half-year results, maintenance schedules, contract delivery and progress against underlying EBIT guidance.

Key Insights

Dyno Nobel Limited (ASX:DNL) entered FY27 with its fertilisers separation completed and FY26 underlying explosives EBIT of AUD 485 million. Statutory profit and underlying earnings reflect different elements of the year's financial performance. The next reporting periods will provide evidence of whether manufacturing performance, transformation measures and new projects progress in line with the company's stated plans.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.